Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers

BACKGROUND: The PD-1/PD-L1 pathway plays critical roles in tumour immunology, and serves as an immune-based therapeutic target. Less is known regarding PD-L2, another ligand of PD-1, and its relation to clinical outcome in human cancers. METHODS: We used a database of 437 surgically and 100 endoscop...

Descripción completa

Detalles Bibliográficos
Autores principales: Okadome, Kazuo, Baba, Yoshifumi, Nomoto, Daichi, Yagi, Taisuke, Kalikawe, Rebecca, Harada, Kazuto, Hiyoshi, Yukiharu, Nagai, Yohei, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Iwagami, Shiro, Miyamoto, Yuji, Yoshida, Naoya, Watanabe, Masayuki, Komohara, Yoshihiro, Shono, Takashi, Sasaki, Yutaka, Baba, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217865/
https://www.ncbi.nlm.nih.gov/pubmed/32210369
http://dx.doi.org/10.1038/s41416-020-0811-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217865/
https://www.ncbi.nlm.nih.gov/pubmed/32210369
http://dx.doi.org/10.1038/s41416-020-0811-0

Ejemplares similares